Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts BPH Energy LimitedPEP11 Offshore Petroleum Joint Venture Update March 18, 2025 Blue Lagoon Completes Second Tranche of Private Placement – Crescat Capital, Phoenix Gold Fund and Nicola Mining Increase Their Positions. March 18, 2025 How to Invest in Natural Gas: Stocks, ETFs and Futures March 18, 2025
Blue Lagoon Completes Second Tranche of Private Placement – Crescat Capital, Phoenix Gold Fund and Nicola Mining Increase Their Positions. March 18, 2025